Gastroenterology & Hepatology

Gutamin 550

Rifaximin (550mg)

Gutamin 550 pack
New LaunchRx Only

About this product

Broad In-Gut Antibacterial Activity against a wide range of gram-positive, gram-negative, aerobic, and anaerobic gut organisms.

Composition
Rifaximin (550mg)
Gutamin 550 composition as printed on the pack
As printed on the pack
Therapy Area
Gastroenterology & Hepatology
Formulation
Tablet
Pack
Strip of 10
Storage
Store in a Cool, dry and dark place

Overview

Gutamin 550 addresses the key limitations of existing hepatic encephalopathy management options such as lactulose monotherapy's unpredictable titration and breakthrough episodes, systemic antibiotics like neomycin with their nephrotoxicity and ototoxicity risks, and escalating lactulose doses that fail to target bacterial ammonia production while risking dehydration. With minimal systemic absorption, it stays concentrated in the gut lumen where ammonia-producing bacteria reside, limiting systemic side effects and drug interactions while offering broad antibacterial activity against the gram-positive, gram-negative, aerobic, and anaerobic organisms implicated in ammonia production.

Indications

Reduction in risk of recurrence of overt hepatic encephalopathy (OHE) in adults with cirrhosis, usually as an add-on to lactulose.
Management of travellers' diarrhoea caused by non-invasive strains of E. coli, in patients without fever or blood in the stool.
Adjunctive management of irritable bowel syndrome with diarrhoea (IBS-D) in adults, where approved by the locally authorised label.
Rx only. For use under medical supervision. Intended for healthcare professionals in India.

Partner With Schemic Concepts

Engineer better health outcomes with precision-driven pharmaceuticals

Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it

Partner With Us